301 related articles for article (PubMed ID: 31292670)
1. Role of the human N-acetyltransferase 2 genetic polymorphism in metabolism and genotoxicity of 4, 4'-methylenedianiline.
Salazar-González RA; Zhang X; Doll MA; Lykoudi A; Hein DW
Arch Toxicol; 2019 Aug; 93(8):2237-2246. PubMed ID: 31292670
[TBL] [Abstract][Full Text] [Related]
2. 4,4'-methylenedianiline-induced hepatotoxicity is modified by N-acetyltransferase 2 (NAT2) acetylator polymorphism in the rat.
Zhang X; Lambert JC; Doll MA; Walraven JM; Arteel GE; Hein DW
J Pharmacol Exp Ther; 2006 Jan; 316(1):289-94. PubMed ID: 16192314
[TBL] [Abstract][Full Text] [Related]
3. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
4. N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes.
Habil MR; Doll MA; Hein DW
Pharmacogenet Genomics; 2020 Apr; 30(3):61-65. PubMed ID: 31895247
[TBL] [Abstract][Full Text] [Related]
5. Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.
Hein DW; Zhang X; Doll MA
Toxicol Lett; 2018 Feb; 283():100-105. PubMed ID: 29180287
[TBL] [Abstract][Full Text] [Related]
6. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
7. Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes.
Leggett CS; Doll MA; States JC; Hein DW
Arch Toxicol; 2021 Jan; 95(1):311-319. PubMed ID: 33136180
[TBL] [Abstract][Full Text] [Related]
8. Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.
Doll MA; Zang Y; Moeller T; Hein DW
J Pharmacol Exp Ther; 2010 Aug; 334(2):540-4. PubMed ID: 20430842
[TBL] [Abstract][Full Text] [Related]
9. N-acetyltransferase 2 acetylator genotype-dependent N-acetylation and toxicity of the arylamine carcinogen β-naphthylamine in cryopreserved human hepatocytes.
Habil MR; Salazar-González RA; Doll MA; Hein DW
Arch Toxicol; 2022 Dec; 96(12):3257-3263. PubMed ID: 36112171
[TBL] [Abstract][Full Text] [Related]
10. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
11. Effect of N-acetyltransferase 2 genetic polymorphism on 4,4'-methylenebis(2-chloroaniline)-induced genotoxicity and oxidative stress.
Habil MR; Salazar-González RA; Doll MA; Hein DW
Arch Toxicol; 2023 Jun; 97(6):1773-1781. PubMed ID: 37142755
[TBL] [Abstract][Full Text] [Related]
12. Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes.
Salazar-González RA; Doll MA; Hein DW
Sci Rep; 2020 May; 10(1):7566. PubMed ID: 32372066
[TBL] [Abstract][Full Text] [Related]
13. Role of the N-acetylation polymorphism in solithromycin metabolism.
Hein DW; Doll MA
Pharmacogenomics; 2017 Jun; 18(8):765-772. PubMed ID: 28625123
[TBL] [Abstract][Full Text] [Related]
14. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
Jefferson FA; Xiao GH; Hein DW
Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621
[TBL] [Abstract][Full Text] [Related]
15. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
16. Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamster.
Ferguson RJ; Doll MA; Rustan TD; Hein DW
Pharmacogenetics; 1996 Feb; 6(1):55-66. PubMed ID: 8845861
[TBL] [Abstract][Full Text] [Related]
17.
Allen CE; Doll MA; Hein DW
Drug Metab Dispos; 2017 Dec; 45(12):1276-1281. PubMed ID: 29018032
[TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes.
Doll MA; Hein DW
Arch Toxicol; 2017 Jul; 91(7):2655-2661. PubMed ID: 28516247
[TBL] [Abstract][Full Text] [Related]
19. Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamster.
Hein DW; Doll MA; Xiao GH; Feng Y
Pharmacogenetics; 2003 Mar; 13(3):159-67. PubMed ID: 12618593
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
Hein DW
Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
